HIPK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.277600E-01
Normal-vs-Stage2
9.827000E-01
Normal-vs-Stage3
1.429040E-01
Normal-vs-Stage4
3.206400E-01
Stage1-vs-Stage2
7.250600E-01
Stage1-vs-Stage3
1.063600E-01
Stage1-vs-Stage4
3.698800E-01
Stage2-vs-Stage3
1.590800E-01
Stage2-vs-Stage4
1.872410E-01
Stage3-vs-Stage4
2.163700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.197800E-01
Normal-vs-AfricanAmerican
5.521000E-01
Normal-vs-Asian
3.846600E-01
Caucasian-vs-AfricanAmerican
3.491200E-01
Caucasian-vs-Asian
1.677980E-01
AfricanAmerican-vs-Asian
7.750400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.421800E-01
Normal-vs-Female
9.939400E-01
Male-vs-Female
8.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.793400E-01
Normal-vs-Age(41-60Yrs)
7.045200E-01
Normal-vs-Age(61-80Yrs)
8.138600E-01
Normal-vs-Age(81-100Yrs)
2.313600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.209600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.350200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.774400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.481900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.577400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.455610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.220600E-01
Normal-vs-Daily Drinker
3.415600E-01
Normal-vs-Weekly Drinker
8.025400E-01
Normal-vs-Occasional Drinker
8.351200E-01
Normal-vs-Social Drinker
7.256800E-01
Non Drinker-vs-Daily Drinker
4.065200E-01
Non Drinker-vs-Weekly Drinker
6.202800E-01
Non Drinker-vs-Occasional Drinker
1.554600E-01
Non Drinker-vs-Social Drinker
1.828630E-01
Daily Drinker-vs-Weekly Drinker
2.993200E-01
Daily Drinker-vs-Occasional Drinker
4.885600E-02
Daily Drinker-vs-Social Drinker
1.024800E-01
Weekly Drinker-vs-Occasional Drinker
4.351600E-01
Weekly Drinker-vs-Social Drinker
3.223200E-01
Occasional Drinker-vs-Social Drinker
6.371600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.663830E-01
Normal-vs-Grade 2
9.184000E-02
Normal-vs-Grade 3
5.569800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.523000E-01
Grade 1-vs-Grade 3
5.588200E-01
Grade 1-vs-Grade 4
1.663830E-01
Grade 2-vs-Grade 3
6.941400E-01
Grade 2-vs-Grade 4
9.184000E-02
Grade 3-vs-Grade 4
5.569800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.206000E-01
Normal-vs-NonDiabetic
8.168600E-01
Diabetic-vs-NonDiabetic
9.178200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.562400E-01
Normal-vs-NoPancreatitis
8.903200E-01
Pancreatitis-vs-NoPancreatitis
1.406960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.049200E-01
Normal-vs-N1
9.908200E-01
N0-vs-N1
6.456800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.339800E-01
Normal-vs-TP53-NonMutant
9.169200E-01
TP53-Mutant-vs-TP53-NonMutant
3.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
